MEMPHASYS LIMITED. — Declaration of Voting Results & Voting Rights Announcements 2011

Nov 28, 2011

==> picture [196 x 25] intentionally omitted <==

==> picture [196 x 25] intentionally omitted <==

==> picture [196 x 25] intentionally omitted <==

==> picture [196 x 24] intentionally omitted <==

FOR IMMEDIATE RELEASE

Results of Annual General Meeting

Sydney, Australia 29[td] November 2011 - NuSep Holdings Limited (ASX: NSP) advises that all resolutions were considered on a poll at the meeting. Resolutions 1 to 4 (inclusive) were passed and Resolutions 5 and 6 did not pass.

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, NuSep Holding Limited advises that the result of each resolution that was tabled at the AGM is as set out in the summary below. The number of proxy votes and their direction is as at the close of proxies on 27 November 2011.

.

Resolution 1- Remuneration Report

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	47,015,096
Proxy Votes Against the Resolution	16,317,340
Proxy Votes Abstaining	19,956,615
Proxy Votes Exercised at the Discretion of the Proxy	3,599,449

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	53,746,626
Against the Resolution	20,200,350
Abstainingon the Resolution	14,118,320

Resolution 2- Director Appointment- Mr John O’Connor

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	56,929,549
Proxy Votes Against the Resolution	2,977,698
Proxy Votes Abstaining	2,516,560
Proxy Votes Exercised at the Discretion of the Proxy	24,473,693

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	67,825,041
Against the Resolution	17,536,014
Abstainingon the Resolution	2,704,241

Contact Details

Telephone +61 2 8415 7300 Facsimile +61 2 8415 7399

NuSep Holdings Ltd 324 Burns Bay Rd Lane Cove NSW 2066

Email info@nusep.com Web www.nusep.com ABN 33 120 047 556

Postal Address

P.O. Box 823 Lane Cove NSW 1595

– 2 –

Resolution 3- Director Appointment- Mr David Roffe

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	56,814,326
Proxy Votes Against the Resolution	2,854,849
Proxy Votes Abstaining	2,442,955
Proxy Votes Exercised at the Discretion of the Proxy	24,785,370

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	68,041,005
Against the Resolution	17,393,655
Abstainingon the Resolution	2,630,636

Resolution 4- Director Appointment- Mr Ward Wescott

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	57,296,207
Proxy Votes Against the Resolution	2,823,211
Proxy Votes Abstaining	1,997,733
Proxy Votes Exercised at the Discretion of the Proxy	24,780,349

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	68,522,886
Against the Resolution	17,356,996
Abstainingon the Resolution	2,185,414

Resolution 5- Appointment of Member Nominated Director- Dr Ian Nisbet

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	20,152,219
Proxy Votes Against the Resolution	56,869,687
Proxy Votes Abstaining	181,409
Proxy Votes Exercised at the Discretion of the Proxy	9,694,185

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	20,435,780
Against the Resolution	67,260,426
Abstainingon the Resolution	369,090

– 3 –

Resolution 6- Appointment of Member Nominated Director- Mr Terry O’Dwyer

Total number of proxy votes

Total number of proxy votes
Proxy Votes for the Resolution	20,117,787
Proxy Votes Against the Resolution	56,901,950
Proxy Votes Abstaining	181,409
Proxy Votes Exercised at the Discretion of the Proxy	9,696,354

Total number of votes cast on the poll

Total number of votes cast on the poll
In Favour for the Resolution	20,403,517
Against the Resolution	67,292,689
Abstainingon the Resolution	369,090

ENDS

For more information please contact:

Contact: Tom Rowe Company Secretary +61 2 8280 7871

About NuSep

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep recently acquired BioInquire which developed the ProteoIQ software enabling NuSep to offer a total Proteomics solution from Fraction to Function . The company has offices in both Sydney Australia and Atlanta, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification.

NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

NuSep Products:

==> picture [12 x 17] intentionally omitted <==

• Gels – NuSep manufactures and sells precast gels including the innovative nUView Gels, which can be visualised 2 minutes after use.

==> picture [12 x 17] intentionally omitted <==

• Separation Instruments – NuSep has developed two unique biological separation instruments. The ProteomeSep was released in 2009 and can separate biological samples into 8 fractions for use in the proteomic market. The SpermSep separates sperm for fertility treatments such as IVF and is expected to undergoing clinical trials later this year.

==> picture [12 x 17] intentionally omitted <==

• Proteomics Software – NuSep offers the unique ProteoIQ software for the analysis of complex mass spec samples. This software is also designed to identify bio markers.

==> picture [12 x 17] intentionally omitted <==

• Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin .

– 4 –

For more information about NuSep please visit the company’s website www.NuSep.com

About PrIME Biologics Pte Ltd

PrIME Biologics is a Singapore based biotech company that has developed a disposable procedure for the processing of plasma proteins. PrIME Biologics is currently a wholly owned subsidiary of NuSep Holdings Limited (ASX: NSP). PrIME Biologics process is based on the Pr eparative I solation by M embrane E lectrophoresis (PrIME) technology developed by NuSep. PrIME provides disposable modular processing that is ‘electronically’ driven membrane fractionation.

The PrIME process increases product yields to over 90% relative to the existing process 50% while increasing product safety. Further, PrIME Biologics process can produce multiple plasma products in hours compared to days, which is required by the current manufacturers.

The initial application for the PrIME process will be the Currently Unprocessable Plasma which represents approximately 50% of all the plasma collected in many countries.